Oath Surgical, a next-generation medical technology company, has successfully raised $24 million in its Series A funding round, with participation from FPV Ventures, McKesson Ventures, OSE, Black Opal Ventures, Tau Ventures, and Rogue VC.

The funding marks a pivotal moment for Oath Surgical’s mission  -  to redefine the landscape of minimally invasive surgery (MIS) through intelligent, adaptive robotic systems that enhance precision, safety, and patient outcomes.

Founded by Dr. Oliver Keown, a physician and innovator with a background in both clinical medicine and venture investment, Oath Surgical is bridging the gap between human dexterity and robotic consistency. The company’s technology aims to give surgeons the intelligence of AI, the control of robotics, and the intuition of human expertise  -  all in one platform.

---

Reimagining the Future of Surgical Precision

In modern medicine, minimally invasive surgery has already revolutionized patient care by reducing recovery times, minimizing scarring, and lowering the risk of infection. However, even as tools and techniques have advanced, surgeons still face major challenges: limited visibility, inconsistent control, and fatigue during complex procedures.

Oath Surgical’s approach focuses on augmenting human performance rather than replacing it. Its proprietary adaptive surgical system leverages real-time imaging, machine learning, and precision robotics to provide dynamic assistance throughout a procedure. The platform continuously interprets the surgical field and adjusts to the surgeon’s movements  -  amplifying precision while maintaining intuitive control.

This hybrid model  -  human-led, machine-enhanced  -  could define the future of surgery itself.

---

The Founder’s Vision: Human Skill Meets Machine Intelligence

As both a doctor and a technologist, Dr. Oliver Keown saw the limitations of surgical robotics firsthand. “Surgeons don’t need more complexity,” he once noted, “they need tools that think alongside them.”

That insight became the foundation for Oath Surgical’s mission: to build AI-powered surgical systems that feel like an extension of the surgeon’s own hands.

Dr. Keown’s unique perspective  -  honed through years in healthcare innovation and investment  -  enables Oath Surgical to operate at the intersection of clinical empathy and engineering excellence. He envisions a world where the surgeon’s intuition is amplified by real-time AI insights, not overridden by automation.

This philosophy underscores a key shift in medical technology: the move from assistance to augmentation.

---

How Oath Surgical’s Technology Works

At its core, Oath Surgical’s system combines three critical technologies:

1. AI-Powered Surgical Guidance – The platform continuously maps the surgical site using advanced imaging and AI interpretation, identifying structures, risk zones, and optimal paths in real time.
   
2. Robotic Precision Control – A lightweight robotic arm enhances micro-movements, minimizing tremors and enabling near-microscopic accuracy.
   
3. Adaptive Haptic Feedback – Surgeons receive real-time tactile responses that simulate the “feel” of tissue interaction, improving safety and control during delicate maneuvers.
   

Together, these systems allow Oath Surgical to offer a surgical experience that is faster, safer, and more precise  -  reducing complications and improving patient recovery times.

---

The Ultra Value Drop: Strategic Insight for Founders in Deep-Tech Healthcare

There’s a powerful insight hidden in Oath Surgical’s approach that founders across industries can learn from:

Disruption doesn’t always mean replacement  -  it can mean amplification.

Many startups make the mistake of positioning AI or automation as a full substitute for human labor. Oath Surgical instead positions its technology as a partner, not a replacement. This distinction unlocks a wider market  -  because it doesn’t threaten existing workflows, it enhances them.

For founders, this serves as a blueprint: when tackling legacy systems like healthcare, education, or finance, the key to adoption is collaboration, not confrontation. Build tools that extend human capacity rather than remove it.

Oath’s genius lies not just in its technology, but in its empathy  -  understanding that the best innovations are the ones that make experts more powerful, not obsolete.

---

The Investors Behind the Vision

The Series A round attracted some of the most forward-thinking investors in the healthcare and deep-tech space.

FPV Ventures and McKesson Ventures bring a blend of healthcare operations and strategic capital, giving Oath access to networks that accelerate commercialization. Black Opal Ventures and Tau Ventures strengthen the company’s presence in AI and medtech innovation, while OSE and Rogue VC add global experience and technical depth.

This strategic mix of investors represents not only financial support but also a shared belief that the operating room is the next frontier for AI-driven transformation.

---

Market Outlook: AI in Surgery Is Just Beginning

The surgical robotics market is currently valued at $14.5 billion (2024) and is projected to surpass $30 billion by 2030, growing at a CAGR of 12.4% (Grand View Research). The push toward automation and digital precision is being accelerated by factors like physician shortages, hospital cost pressures, and an aging population requiring more procedures.

However, the greatest shift isn’t hardware  -  it’s intelligence. AI integration in medical robotics is expected to grow at over 20% CAGR, as hospitals move from mechanical assistance to decision-augmented systems.

That’s exactly where Oath Surgical positions itself  -  not as just another surgical robot manufacturer, but as a platform for intelligent surgical augmentation.

By focusing on adaptability, Oath can serve both specialized surgical centers and large healthcare networks, scaling across geographies and specialties.

---

What’s Next for Oath Surgical

With its new funding, Oath Surgical plans to expand its engineering and clinical validation teams, accelerate regulatory approvals, and prepare for pilot deployments in major hospitals. The company will also advance its R&D to integrate AI-driven training modules, allowing surgeons to simulate and refine procedures in virtual environments before live operations.

This move reflects Oath’s holistic philosophy: the future of surgery isn’t just in machines  -  it’s in merging technology with human mastery.

Dr. Keown and his team are building not just a device, but a framework for the next generation of surgical collaboration  -  one where every movement, decision, and outcome benefits from the power of intelligence.

As the company continues its journey, Oath Surgical stands at the forefront of a profound transformation in medicine  -  one where the promise of AI meets the precision of the human hand.